CD326, also known as epithelial cell adhesion/activating molecule (EpCAM),[20] is expressed at high levels in human breast cancers[21] as well as 4T1, EMT‐6, and MCF‐7 cells (Figure S5A, Supporting Information). Here, EPCAM is linked to breast cancer.